Safety of auto-transfusion during pancreatic surgery

Protocol: 
AAAN7402
Phase: 
I

A pilot study to determine the safety of recovered blood intended for auto- transfusion during pancreatic cancer operations

Prospective protocol assessing the safety of autologous blood transfusions following pancreatectomy for pancreatic ductal adenocarcinoma (PDAC)

Are you Eligible? (Inclusion Criteria)

Inclusion

Over 18 years of age undergoing open operation for biopsy confirmed pancreatic cancer

Exclusion

Past medical history of other primary non-skin malignancy, or history of Hepatitis B, C or HIV infection or high risk behaviors and unwilling to be tested

Specialty Area(s)

Trial Location

Columbia University Medical Center
HIP (The Herbert Irving Pavilion)
8th Floor
New York, NY 10032
United States